Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jean Oak"'
Autor:
Matthew J. Frank, John Baird, Anne Kramer, Shabnum Patel, Bita Sahaf, Juliana Craig, Emma Crawford, Sheren Younes, Jean Oak, Yasodha Natkunan, Jay Spiegel, Zachary Ehlinger, Harshini Chinnasamy, Warren Reynolds, Hrishi Srinagesh, Yi-Jiun Su, Emily Egeler, Steven Feldman, Crystal Mackall, Lori Muffly, David Miklos
Publikováno v:
HemaSphere, Vol 7, p e3362169 (2023)
Externí odkaz:
https://doaj.org/article/f37aa0e9cdbc48e78c6c20ac96a00324
Autor:
Crystal L Mackall, Christina Baggott, Kara Lynn Davis, Liora Schultz, Ann Walkush, Courtney Erickson, Sneha Ramakrishna, Catherine Aftandilian, Norman Lacayo, Helen Ruth Nadel, Jean Oak
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 2 (2023)
Background: Chimeric antigen receptor (CAR) T cell therapy is an effective salvage therapy for pediatric relapsed B-cell acute lymphoblastic leukemia (B-ALL), yet is challenged by high rates of post-CAR relapse. Literature describing specific relapse
Externí odkaz:
https://doaj.org/article/0898e66bc0de4d3099ca0993cfc0cfe9
Autor:
Wei Gu, Eric Talevich, Elaine Hsu, Zhongxia Qi, Anatoly Urisman, Scot Federman, Allan Gopez, Shaun Arevalo, Marc Gottschall, Linda Liao, Jack Tung, Lei Chen, Harumi Lim, Chandler Ho, Maya Kasowski, Jean Oak, Brittany J. Holmes, Iwei Yeh, Jingwei Yu, Linlin Wang, Steve Miller, Joseph L. DeRisi, Sonam Prakash, Jeff Simko, Charles Y. Chiu
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-11 (2021)
Abstract Background Metagenomic next-generation sequencing (mNGS) of body fluids is an emerging approach to identify occult pathogens in undiagnosed patients. We hypothesized that metagenomic testing can be simultaneously used to detect malignant neo
Externí odkaz:
https://doaj.org/article/03436cd749174bfe8eee0110b5e5db0b
Autor:
Crystal Mackall, Alice Bertaina, Steven Feldman, Christina Baggott, Bita Sahaf, Kara Lynn Davis, Liora Schultz, Courtney Erickson, Sneha Ramakrishna, Jean Oak, Robbie G Majzner, Shabnum Patel, Neehar Bhatia
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Chimeric antigen receptor (CAR) therapy and hematopoietic stem cell transplantation (HSCT) are therapeutics for relapsed acute lymphocytic leukemia (ALL) that are increasingly being used in tandem. We identified a non-physiologic CD19+/CD3
Externí odkaz:
https://doaj.org/article/655f1d8061314500801f36eba62481ed
Autor:
Kunwar Singh, Lhara S. Lezama, Jason Kurzer, Jean Oak, Liora M. Schultz, Ann Walkush, Tse-Chang Cheng, Everett H. Chen, William A. May, Cheryl Chang, Michael P. Link, Ranjana H. Advani, Carlos J. Suarez, Yasodha Natkunam
Publikováno v:
American Journal of Surgical Pathology. 47:81-90
Classic Hodgkin lymphoma (CHL) patients may infrequently present with a prior or recurrent disease with discordant histology resembling non-Hodgkin lymphomas. These include primary mediastinal large B-cell lymphoma (PMBL), diffuse large B-cell lympho
Autor:
Edgar E. Robles, Ye Jin, Padhraic Smyth, Richard H. Scheuermann, Jack D. Bui, Huan-You Wang, Jean Oak, Yu Qian
Publikováno v:
medRxiv
MotivationPrecise identification of cancer cells in patient samples is essential for accurate diagnosis and clinical monitoring but has been a significant challenge in machine learning approaches for cancer precision medicine. In most scenarios, trai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b3e07602ba425efe84eb66b074f22f9
https://europepmc.org/articles/PMC9934808/
https://europepmc.org/articles/PMC9934808/
Autor:
Warren D. Reynolds, Bita Sahaf, Zachary Ehlinger, Steven A. Feldman, Matthew J. Frank, Andrew R. Rezvani, Surbhi Sidana, Jay Y. Spiegel, Allison P. Jacob, Lori Muffly, Kara L. Davis, Shabnum Patel, Jean Oak, Eric H. Yang, Ilan R. Kirsch, Robert Lowsky, Laura Johnston, Juliana Craig, John S. Tamaresis, Michael G. Ozawa, John H. Baird, Sheren F. Younes, David B. Miklos, Parveen Shiraz, Chelsea D. Mullins, Crystal L. Mackall, Robert S. Negrin, Liora M. Schultz, Wen-Kai Weng, Everett Meyer, Sally Arai, Yasodha Natkunam, Sneha Ramakrishna
Publikováno v:
Blood
The prognosis of patients with large B-cell lymphoma (LBCL) that progresses after treatment with chimeric antigen receptor (CAR) T-cell therapy targeting CD19 (CAR19) is poor. We report on the first 3 consecutive patients with autologous CAR19-refrac
Autor:
Grace Y E, Kim, Morteza, Noshad, Henning, Stehr, Rebecca, Rojansky, Dita, Gratzinger, Jean, Oak, Rondeep, Brar, David, Iberri, Christina, Kong, James, Zehnder, Jonathan H, Chen
Publikováno v:
AMIA Annu Symp Proc
Advancing diagnostic testing capabilities such as clinical next generation sequencing methods offer the potential to diagnose, risk stratify, and guide specialized treatment, but must be balanced against the escalating costs of healthcare to identify
Autor:
Jean Oak, Michael S. Khodadoust, Sebastian Fernandez-Pol, Kerri E. Rieger, Bruce Petersen, Jo-Ellen Murphy, Erica B.K. Wang, Youn H. Kim, Carlos Suárez
Publikováno v:
American Journal of Surgical Pathology. 45:193-199
Lymphocyte variant hypereosinophilic syndrome (LV-HES) is a rare cause of eosinophilia that is due to eosinophilipoietic cytokine production by an immunophenotypically abnormal T-cell clone. The molecular pathogenesis of this disorder is largely unkn
Publikováno v:
American Journal of Clinical Pathology. 154:215-224
Objectives Kikuchi-Fujimoto disease (KFD) and systemic lupus erythematosus (SLE) are benign entities with histologic features that raise concern about malignancy and infection. We searched for a histology-independent KFD/SLE signature relying on only